Stay updated on Pembrolizumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.

Latest updates to the Pembrolizumab in Multiple Myeloma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe two screenshots show only minor layout and formatting adjustments to the study details page, with no changes to core study content (title, identifiers, eligibility criteria, design, or outcome measures). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a new MedlinePlus Genetics topic: Multiple myeloma, expanding the core content to include genetics-related information on this disease. No deletions. If this is a medical information page, expect broader coverage on genetics and multiple myeloma.SummaryDifference0.2%

- Check43 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%

- Check50 days agoChange DetectedAdds broader topic coverage (Multiple myeloma) and updates version to v3.1.0; removes the previous MedlinePlus Genetics topic link and the term 'Plasma cell myeloma' plus older revision v3.0.2.SummaryDifference0.5%

- Check57 days agoChange DetectedAdded a new MedlinePlus Genetics topic: Multiple myeloma, expanding core content with genetics-related information.SummaryDifference0.2%

- Check65 days agoChange DetectedVersion updated to v3.0.2; removed the MedlinePlus Genetics topic 'Multiple myeloma' as well as the prior v3.0.1 note and the Back to Top link.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.